217 related articles for article (PubMed ID: 20795680)
1. Potent mutagenicity of 3-methylindole requires pulmonary cytochrome P450-mediated bioactivation: a comparison to the prototype cigarette smoke mutagens B(a)P and NNK.
Weems JM; Lamb JG; D'Agostino J; Ding X; Yost GS
Chem Res Toxicol; 2010 Nov; 23(11):1682-90. PubMed ID: 20795680
[TBL] [Abstract][Full Text] [Related]
2. 3-Methylindole is mutagenic and a possible pulmonary carcinogen.
Weems JM; Cutler NS; Moore C; Nichols WK; Martin D; Makin E; Lamb JG; Yost GS
Toxicol Sci; 2009 Nov; 112(1):59-67. PubMed ID: 19700606
[TBL] [Abstract][Full Text] [Related]
3. 3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively.
Weems JM; Yost GS
Chem Res Toxicol; 2010 Mar; 23(3):696-704. PubMed ID: 20187624
[TBL] [Abstract][Full Text] [Related]
4. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
Jalas JR; Ding X; Murphy SE
Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene.
Wang H; Lanza DL; Yost GS
Arch Biochem Biophys; 1998 Jan; 349(2):329-40. PubMed ID: 9448722
[TBL] [Abstract][Full Text] [Related]
6. Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108.
Kushida H; Fujita K; Suzuki A; Yamada M; Nohmi T; Kamataki T
Mutat Res; 2000 Nov; 471(1-2):135-43. PubMed ID: 11080669
[TBL] [Abstract][Full Text] [Related]
7. Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver.
Koide A; Fuwa K; Furukawa F; Hirose M; Nishikawa A; Mori Y
Mutat Res; 1999 Jul; 428(1-2):165-76. PubMed ID: 10517990
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.
Megaraj V; Zhou X; Xie F; Liu Z; Yang W; Ding X
Carcinogenesis; 2014 Jan; 35(1):131-7. PubMed ID: 23917075
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based inactivation of lung-selective cytochrome P450 CYP2F enzymes.
Kartha JS; Yost GS
Drug Metab Dispos; 2008 Jan; 36(1):155-62. PubMed ID: 17962375
[TBL] [Abstract][Full Text] [Related]
10. Bacterial mutagenicity of cigarette smoke and its interaction with ethanol.
De Flora S; Balansky R; Gasparini L; Camoirano A
Mutagenesis; 1995 Jan; 10(1):47-52. PubMed ID: 7739401
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.
Miyazaki M; Yamazaki H; Takeuchi H; Saoo K; Yokohira M; Masumura K; Nohmi T; Funae Y; Imaida K; Kamataki T
Carcinogenesis; 2005 Nov; 26(11):1947-55. PubMed ID: 15958517
[TBL] [Abstract][Full Text] [Related]
12. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
[TBL] [Abstract][Full Text] [Related]
13. Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures.
Yim SH; Hee SS
Mutat Res; 2001 May; 492(1-2):13-27. PubMed ID: 11377240
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats.
Guo Z; Smith TJ; Thomas PE; Yang CS
Arch Biochem Biophys; 1992 Oct; 298(1):279-86. PubMed ID: 1524438
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes.
Smith GB; Bend JR; Bedard LL; Reid KR; Petsikas D; Massey TE
Drug Metab Dispos; 2003 Sep; 31(9):1134-41. PubMed ID: 12920169
[TBL] [Abstract][Full Text] [Related]
16. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
[TBL] [Abstract][Full Text] [Related]
17. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of stereospecifically deuterated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) iastereomers and metabolism by A/J mouse lung microsomes and cytochrome p450 2A5.
Jalas JR; Hecht SS
Chem Res Toxicol; 2003 Jun; 16(6):782-93. PubMed ID: 12807362
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS
Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity, genotoxicity and transforming activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat tracheal epithelial cells.
Zhu SY; Cunningham ML; Gray TE; Nettesheim P
Mutat Res; 1991 Dec; 261(4):249-59. PubMed ID: 1722280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
